share_log

トレイダーズホールディングス:CVCファンドを通じ、iPS細胞技術によるiPS創薬・再生医療の研究開発を行う「リジェネフロ株式会社」へ出資

Traders Holdings: Invest in “Rege Nephro Co., Ltd.,” which conducts research and development of iPS drug discovery and regenerative medicine using iPS cell technology through the CVC Fund

JPX ·  Oct 9 14:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more